DESTINY PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.75 GBX | -3.08% |
|
-12.50% | -77.50% |
| Apr. 25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
| Apr. 25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DESTINY PHARMA PLC | Bio Therapeutic Drugs | -3.08% | -12.50% | -77.50% | -54.61% | -80.56% | 19.44M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- DEST Stock
- Charts Destiny Pharma plc
- Comparison Chart
